Prevalence and pattern of adverse events following COVID-19 vaccination among adult population in Sokoto metropolis, northwest, Nigeria
PLOS ONE · 2025
DOI: 10.1371/journal.pone.0277585 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Habibullah Adamu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Community Health, Usmanu Danfodiyo University, Sokoto, Nigeria. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, Vaccination. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Patientensicherheit
Abstract (Originalsprache)
Background
COVID-19 still poses a major public health challenge worldwide and vaccination remains one of the major interventions to control the disease. Different types of vaccines approved by the World Health Organization (WHO) are currently in use across the world to protect against the disease. This study assessed the prevalence and pattern of adverse events following immunization (AEFI) after receiving COVID-19 vaccine (the Oxford-AstraZeneca vaccine) among the adult population in Sokoto metropolis, North-west, Nigeria.
Methods
We conducted a cross-sectional study among 230 adults in Sokoto metropolis who received COVID-19 vaccines. Data was collected using a structured questionnaire administered via personal phone calls to respondents who were selected via a systematic sampling technique. For data analysis, IBM SPSS version 25.0 was used.
Results
The majority of the participants [183 (79.7%)] experienced AEFI. The most common adverse events were body weakness [157 (85%)], fever [111 (60.3%)] and headache [103 (56%)]. Up to half of the respondents that experienced AEFI said it occurred within minutes and a few hours, whereas 75 (40.8%) said it was within 2-3 days. Up to 66.3% of the adverse reactions were mild and lasted between a few hours (37.5%) and one day (31.5%); however, 15.2% of the respondents had severe reactions of which 22.7% were admitted to a health facility. The development of AEFI was linked to the presence of an underlying medical condition (p = 0.001), a previous history of AEFI (p = 0.017), and a history of drug reaction (p = 0.005).
Conclusion
The majority of respondents reported adverse events following vaccination with the Oxford-AstraZeneca vaccine; body weakness, fever, and headache being the most common AEFIs. History of underlying medical condition as well as a history of adverse drug reactions were predictors of the development of adverse reactions following COVID-19 vaccination. Service providers at each COVID-19 vaccination point should always take the time to explain to vaccine recipients that adverse reactions are possible; however, they should reassure them that most ARs resolve within a few hours to a few days.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Community Health, Usmanu Danfodiyo University, Sokoto, Nigeria.
- Department of Pharmacology and Therapeutics, Usmanu Danfodiyo University, Sokoto, Nigeria.
ORCID-Profile: Habibullah Adamu
Zitieren
APA
Adamu, H., Lawal, S., Bawa, I. A., Sani, A. M., & Adamu, A. A. (2025). Prevalence and pattern of adverse events following COVID-19 vaccination among adult population in Sokoto metropolis, northwest, Nigeria. PLOS ONE. https://doi.org/10.1371/journal.pone.0277585
Vancouver
Adamu H, Lawal S, Bawa IA, Sani AM, Adamu AA. Prevalence and pattern of adverse events following COVID-19 vaccination among adult population in Sokoto metropolis, northwest, Nigeria. PLOS ONE. 2025. doi:10.1371/journal.pone.0277585
BibTeX
@article{Adamu2025,
author = {Adamu, Habibullah and Lawal, Sufyanu and Bawa, Ishaka Alhaji and Sani, Akilu Muhammad and Adamu, Adamu Ahmed},
title = {Prevalence and pattern of adverse events following COVID-19 vaccination among adult population in Sokoto metropolis, northwest, Nigeria},
journal = {PLOS ONE},
year = {2025},
doi = {10.1371/journal.pone.0277585}
}
EUVIMED